Utama › Skleroderma › New York › New York City
Kajian klinikal Skleroderma di New York City, NY
11 kajian untuk Skleroderma sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Mengambil pesertaFasa 3
- Hospital for Special Surgery, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Mengambil pesertaFasa 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Mengambil pesertaFasa 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Mengambil pesertaFasa 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Platform Clinical Study for Conquering Scleroderma
Mengambil pesertaFasa 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Mengambil pesertaFasa 2/3
- Columbia University Irving Medical Center, New York
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Mengambil pesertaFasa 1/2
- Nkarta Investigational Site, New York
A Study of AZD0120 in Autoimmune Diseases
Mengambil pesertaFasa 1
- Research Site, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Mengambil pesertaFasa 1
- Montefiore Medical Center, New York
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Mengambil pesertaFasa 2
- Hospital for Special Surgery, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Mengambil pesertaFasa 2
- aTyr Investigative Site, New York
Kajian Skleroderma di bandar lain
- Ann Arbor, MI10 kajian
- Chicago, IL10 kajian
- Houston, TX9 kajian
- Boston, MA7 kajian
- Durham, NC7 kajian
- Los Angeles, CA7 kajian
- New Orleans, LA6 kajian
- Philadelphia, PA6 kajian
- Baltimore, MD6 kajian
- Dallas, TX5 kajian
- Pittsburgh, PA5 kajian
- Plantation, FL4 kajian
Kajian lain di New York City
- Kanser Payudara134 kajian
- Kanser Paru-paru Bukan Sel Kecil120 kajian
- Kanser (semua jenis)110 kajian
- Kanser Prostat103 kajian
- Kanser Metastatik93 kajian
- Kanser Kolorektal77 kajian
- Kanser Ovari69 kajian
- Kanser Paru-paru60 kajian
- Kanser Pankreas60 kajian
- Mieloma Pelbagai60 kajian
- Kanser Endometrium52 kajian
- Kegagalan Jantung51 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.